-transparent.png){kind=logo}
Comparative evaluation of six commercial rubella virus antibody kits is described. A set of serum samples skewed toward nonreactive and low-positive rubella antibody levels was used because the goal of an immunity screening test is the detection of susceptible individuals. The M. A. Bioproducts Rubastat and the Hynson, Westcott and Dunning Rubascan were superior in achieving high sensitivity, specificity, and reproducibility. They also were the easiest and fastest tests to perform, and they require equipment available in most laboratories.
Related Publications
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
June 1984,
Journal of clinical microbiology,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
March 1999,
American journal of clinical pathology,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
May 1989,
Enfermedades infecciosas y microbiologia clinica,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
October 1963,
Science (New York, N.Y.),
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
June 2013,
Helicobacter,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
December 1984,
Kaku igaku. The Japanese journal of nuclear medicine,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
March 1992,
Journal of clinical microbiology,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
September 1972,
CRC critical reviews in clinical laboratory sciences,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
October 1993,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
R A Wittenburg, and
M A Roberts, and
L B Elliott, and
L M Little
April 1975,
Seminars in nuclear medicine,
